Neurosurgery at an earlier stage of Parkinson disease
Authors:
- W.M.M. SchüpbachWSW.M.M. Schüpbach
- D. MaltêteDMD. Maltête
- J. L. HouetoJHJ. L. Houeto
- S. Tezenas du MontcelSMS. Tezenas du Montcel
- L. MalletLML. Mallet
- M. L. WelterMWM. L. Welter
- M. GargiuloMGM. Gargiulo
- C. BéharCBC. Béhar
- A. M. BonnetABA. M. Bonnet
- V. CzerneckiVCV. Czernecki
- B. PidouxBPB. Pidoux
- S. NavarroSNS. Navarro
- 23 January 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 68 (4) , 267-271
Abstract
Stimulation of the subthalamic nucleus is an effective treatment for advanced Parkinson disease (PD) and is currently performed after a mean disease duration of 14 years, when severe motor complications have resulted in marked loss of quality of life. We examined whether surgery at an early stage would maintain quality of life as well as improve motor function. Twenty patients with PD of short duration (time elapsed since first symptom +/- SD: 6.8 +/- 1.0 years) with mild to moderate motor signs (Unified Parkinson's Disease Rating Scale III "off" medication: 29 +/- 12) who responded well to levodopa treatment were included in pairs, matched for age, duration and severity of disease, and impairment in socioprofessional functioning. Patients were prospectively randomized to undergo bilateral subthalamic nucleus stimulation (n = 10) or receive optimized medical treatment (n = 10). Parkinsonian motor scores, quality of life, cognition, and psychiatric morbidity were assessed at inclusion and at 6, 12, and 18 months after randomization. Quality of life was improved by 24% in surgical and 0% in nonsurgical patients (p < 0.05). After 18 months, the severity of parkinsonian motor signs "off" medication, levodopa-induced motor complications, and daily levodopa dose were reduced by 69%, 83%, and 57% in operated patients and increased by 29%, 15%, and 12% in the group with medical treatment only (p < 0.001). Adverse events were mild or transient, and overall psychiatric morbidity and anxiety improved in the surgical group. Subthalamic nucleus stimulation should be considered a therapeutic option early in the course of Parkinson disease.Keywords
This publication has 25 references indexed in Scilit:
- Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow upJournal of Neurology, Neurosurgery & Psychiatry, 2005
- The effect of deep brain stimulation on quality of life in movement disordersJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-upBrain, 2005
- Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Parkinson's disease: neurosurgery at an earlier stage?Journal of Neurology, Neurosurgery & Psychiatry, 2002
- Behavioural disorders, Parkinson's disease and subthalamic stimulationJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidanceJournal of Neurosurgery, 2000
- The development and validation of a short measure of functioning and well being for individuals with Parkinson's diseaseQuality of Life Research, 1995
- The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979